Nanomicelle-Based Redox-Responsive Dual-Prodrug for Synergistic Breast Cancer Chemo-Immunotherapy-Reference-Cited by-同舟云学术

Nanomicelle-Based Redox-Responsive Dual-Prodrug for Synergistic Breast Cancer Chemo-Immunotherapy

Published:2023-09-15 Issue:19 Volume:6 Page:18263-18274
ISSN:2574-0970
Container-title:ACS Applied Nano Materials
language:en
Short-container-title:ACS Appl. Nano Mater.

Author:

Zhang Liuwei¹²^ORCID,Zheng Haonan²,Cui Hongyan²,Yin Xiaolan²,Zhang Cheng²,Wang Yue³⁴⁵⁶,Zhao Yan³⁴⁵⁶,Lin Jiaqi²,Wang Zheng⁷,Wang Jingyun¹²^ORCID,Chen Qixian²⁴⁷^ORCID

Affiliation:

1. State Key Laboratory of Fine Chemicals, Dalian University of Technology, No. 2 Linggong Road, Dalian, Liaoning 116024, P. R. China

2. School of Bioengineering, Dalian University of Technology, No. 2 Linggong Road, Dalian, Liaoning 116024, P. R. China

3. Department of Gastric Surgery, Cancer Hospital of Dalian University of Technology, No. 44 Xiaoheyan Road, Shenyang, Liaoning 110042, P. R. China

4. Provincial Key Laboratory of Interdisciplinary Medical Engineering for Gastrointestinal Carcinoma, Liaoning Cancer Hospital & Institute, No. 44 Xiaoheyan Road, Shenyang, Liaoning 110042, P. R. China

5. Department of Gastric Surgery, Cancer Hospital of China Medical University, No. 44 Xiaoheyan Road, Shenyang, Liaoning 110042, P. R. China

6. China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, P. R. China

7. Innovation Center of Yangtze River Delta, Zhejiang University, Jiaxing, Zhejiang 314100, P. R. China

Funder

National Key Research and Development Program of China

Dalian University of Technology

National Natural Science Foundation of China

Department of Health of Zhejiang Province

Liaoning Cancer Hospital and Institute

Shenyang Science and Technology Program

Liaoning Livelihood of the People Science and Technology

Publisher